Edward T. Mathers - Insider Trading & Ownership

Entity
Individual
Location
C/O Medimmune, Inc., One Medimmune Way, Gaithersburg, MD
Summary
The estimated net worth of Edward T. Mathers is at least $316M dollars as of October 8, 2024. Edward T. Mathers is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146M. Edward T. Mathers is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $109M. Edward T. Mathers is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $61.1M. Edward T. Mathers is the Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $343K.
All Insider Reports
All Insider Reports

Ownership of Edward T. Mathers

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146M Jun 28, 2021
SVRA Savara Inc 10%+ Owner $109M Jul 17, 2023
KRRO Korro Bio, Inc. 10%+ Owner $61.1M +$1M +1.66% Apr 22, 2024
RYTM RHYTHM PHARMACEUTICALS, INC. Director $343K Jun 21, 2024
AKUS Akouos, Inc. Director Dec 1, 2022
INZY Inozyme Pharma, Inc. Director Jun 18, 2024
MBX MBX Biosciences, Inc. Director, 10%+ Owner Sep 16, 2024
MIRM Mirum Pharmaceuticals, Inc. Director Jun 2, 2022
NEUE NeueHealth, Inc. 10%+ Owner Oct 1, 2024
OBSV ObsEva SA Director Jan 1, 2023
OKUR OnKure Therapeutics, Inc. Director Oct 4, 2024
SNTI Senti Biosciences, Inc. Director Jul 10, 2024
SYBX SYNLOGIC, INC. Director Jun 22, 2023
TRVI Trevi Therapeutics, Inc. Director Jun 13, 2024

Insider Transactions Reported by Edward T. Mathers:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.